BioCentury
ARTICLE | Company News

Serono licenses antibodies to Knoll and Centocor

July 13, 2000 7:00 AM UTC

Serono (SWX:SEO) has separately granted licenses to Knoll (Ludwigshafen, Germany) and Centocor (Malvern, Penn.) to patents covering monoclonal antibodies to tumor necrosis factor (TNF). Knoll, a subsi...